OTTAWA, April 21, 2017 /CNW/ - As health care spending continues to grow, the need to derive maximum value from every health
Titled "Measuring Value in Theory and the Real World," the CADTH Symposium will be taking a hard look at the issue of value in health care. Some aspects of the value equation are widely acknowledged, such as improving clinical outcomes, providing equitable access to necessary services, using technologies in an appropriate manner, and ceasing to pay for technologies that have no evidence of benefit. However, depending on one's perspective, the definition of value might also include faster access to services, affordability, patient preferences, promoting innovation, or a range of other ethical, legal, or social considerations.
"Everyone likes to talk about value, but, in my experience, there's little consensus on value in health care because it means different things to different stakeholders," says Dr. Brian O'Rourke, President and CEO of CADTH. "We all bring different perspectives to the conversation, which is why I'm looking forward to the CADTH Symposium, where we are bringing together patients, clinicians, industry representatives, and policy-makers for interesting debates about value in health care — providing excellent opportunities to learn from one another."
Running from April 23 to April 25, 2017, the CADTH Symposium covers a range of topics including respecting First Nations, Inuit, and Métis perspectives; the rise of artificial intelligence; complexities of precision medicine; the potential of using real-world data; fair pricing of pharmaceuticals; and incorporating the patient and caregiver views in health care decision-making.
Program highlights include:
In addition, the CADTH Symposium will hold 16 workshops, and 46 panels and oral presentation sessions.
For details about the 2017 CADTH Symposium, view the conference program. Follow CADTH on Twitter (@CADTH_ACMTS) and join the Symposium conversation using the hashtag #CADTHSymp.
About CADTHCADTH is an independent, not-for-profit organization responsible for providing Canada's health care decision-makers with objective evidence to help make informed decisions about the optimal use of drugs and medical devices in our health care system. CADTH receives funding from Canada's federal, provincial, and territorial governments, with the exception of Quebec.
SOURCE Canadian Agency for Drugs and Technologies in Health (CADTH)
Subscribe to our Free Newsletters!
Sarcoma, is a cancer that may arise from several soft-tissues or bone. Treatment in early stages is ...
A wonder drug, soda bicarb or baking soda can be used for skin, teeth, hair, kidneys and much more ...
Melasma, also called as chloasma, is a skin hyperpigmentation problem characterized by brown spots ...View All